PubRank

In-Gu Do

Author PubWeight™ 41.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer 2013 1.43
2 Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol 2008 1.33
3 MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol 2013 1.25
4 Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol 2011 1.22
5 Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing. Genes Chromosomes Cancer 2012 1.19
6 Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol 2011 1.14
7 Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial. Eur J Cancer 2012 1.08
8 Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma. Clin Cancer Res 2010 1.04
9 Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J Exp Clin Cancer Res 2009 1.02
10 Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy. APMIS 2010 1.01
11 Plexiform angiomyxoid myofibroblastic tumor of the stomach: report of two cases and review of the literature. Korean J Pathol 2012 0.99
12 The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. Mod Pathol 2011 0.97
13 High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion. Eur J Cancer 2012 0.96
14 Synchronous gynecologic malignancy and preliminary results of Lynch syndrome. J Gynecol Oncol 2011 0.95
15 Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy. Gynecol Oncol 2011 0.95
16 Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer. Hum Pathol 2012 0.94
17 HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. Int J Cancer 2014 0.93
18 Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma. J Clin Invest 2014 0.92
19 Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer. Int J Cancer 2014 0.92
20 A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. PLoS One 2013 0.90
21 Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci 2010 0.89
22 Lymphatic vessels and high endothelial venules are increased in the sentinel lymph nodes of patients with oral squamous cell carcinoma before the arrival of tumor cells. Ann Surg Oncol 2011 0.89
23 Postoperative prognosis prediction of pancreatic cancer with seven microRNAs. Pancreas 2015 0.88
24 Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients. Invest New Drugs 2013 0.86
25 Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis? Leuk Lymphoma 2011 0.86
26 Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene. PLoS One 2012 0.86
27 Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age. J Neurooncol 2013 0.85
28 Clinical significance of galectin-7 in epithelial ovarian cancer. Anticancer Res 2013 0.84
29 Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma. Int J Clin Oncol 2011 0.84
30 Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Invest New Drugs 2014 0.83
31 Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix. Cancer Biol Ther 2010 0.82
32 A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery. Int J Cancer 2014 0.82
33 Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors. Target Oncol 2013 0.81
34 Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol Rep 2009 0.81
35 Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay. Ann Hematol 2013 0.80
36 Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer. Gynecol Oncol 2012 0.80
37 Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer. J Comput Assist Tomogr 2013 0.79
38 Differential expression of extracellular matrix-related genes in rare variants of meningioma. Hum Pathol 2012 0.79
39 Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. J Surg Oncol 2012 0.79
40 Gastrointestinal stromal tumour with osteoclast-like giant cells and aneurysmal bone cyst-like features. Pathology 2009 0.79
41 A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test. Cancer Chemother Pharmacol 2015 0.78
42 CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer. Ann Surg Oncol 2013 0.77
43 Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH. APMIS 2013 0.77
44 Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma. Ann Surg Oncol 2011 0.77
45 Genetic profiling to predict recurrence of early cervical cancer. Gynecol Oncol 2013 0.77
46 Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma. Genes Chromosomes Cancer 2015 0.76
47 Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol 2012 0.75
48 Expression Pattern of Smad4/GATA3 as a Predictor of Survival in Invasive Ductal Carcinoma of the Breast. Pathobiology 2017 0.75
49 Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Invest New Drugs 2015 0.75